Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial
Grimley, Michael S, Chemaly, Roy F, Englund, Janet A, Kurtzberg, Joanne, Chittick, Gregory, Brundage, Thomas M, Bae, Andrew, Morrison, Marion E, Prasad, Vinod K
Published in Biology of blood and marrow transplantation (01.03.2017)
Published in Biology of blood and marrow transplantation (01.03.2017)
Get full text
Journal Article
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Marty, Francisco M, Winston, Drew J, Rowley, Scott D, Vance, Estil, Papanicolaou, Genovefa A, Mullane, Kathleen M, Brundage, Thomas M, Robertson, Alice T, Godkin, Susan, Momméja-Marin, Hervé, Boeckh, Michael
Published in The New England journal of medicine (26.09.2013)
Published in The New England journal of medicine (26.09.2013)
Get full text
Journal Article
Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
Tippin, Timothy K, Morrison, Marion E, Brundage, Thomas M, Momméja-Marin, Hervé
Published in Therapeutic drug monitoring (01.12.2016)
Published in Therapeutic drug monitoring (01.12.2016)
Get more information
Journal Article
Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study
Zecca, Marco, Wynn, Robert, Dalle, Jean-Hugues, Feuchtinger, Tobias, Vainorius, Enrikas, Brundage, Thomas M., Chandak, Aastha, Mozaffari, Essy, Nichols, Garrett, Locatelli, Franco
Published in Bone marrow transplantation (Basingstoke) (01.10.2019)
Published in Bone marrow transplantation (Basingstoke) (01.10.2019)
Get full text
Journal Article
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT
Hill, Joshua A., Nichols, W. Garrett, Marty, Francisco M., Papanicolaou, Genovefa A., Brundage, Thomas M., Lanier, Randall, Zerr, Danielle M., Boeckh, Michael J.
Published in Blood (23.04.2020)
Published in Blood (23.04.2020)
Get full text
Journal Article
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Marty, Francisco M., Winston, Drew J., Chemaly, Roy F., Mullane, Kathleen M., Shore, Tsiporah B., Papanicolaou, Genovefa A., Chittick, Greg, Brundage, Thomas M., Wilson, Chad, Morrison, Marion E., Foster, Scott A., Nichols, W. Garrett, Boeckh, Michael J.
Published in Biology of blood and marrow transplantation (01.02.2019)
Published in Biology of blood and marrow transplantation (01.02.2019)
Get full text
Journal Article
Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial
Prasad, Vinod K, Papanicolaou, Genovefa A, Marón, Gabriela M, Vainorius, Enrikas, Brundage, Thomas M, Chittick, Greg, Nichols, Garrett, Grimley, Michael S
Published in Biology of blood and marrow transplantation (01.03.2017)
Published in Biology of blood and marrow transplantation (01.03.2017)
Get full text
Journal Article
Monitoring Changes in Serum Albumin (SA) Concentrations As an Early and Objective Indicator of Potential CMX001-Associated Gastrointestinal (GI) Adverse Drug Effects
Mommeja-Marin, Herve, Brundage, Thomas M, Margolskee, Dorothy J
Published in Biology of blood and marrow transplantation (01.02.2013)
Published in Biology of blood and marrow transplantation (01.02.2013)
Get full text
Journal Article
Renal Safety of Broad Spectrum Antiviral CMX001 in the Prevention of CMV Infection Post- Allogeneic Hematopoietic Cell Transplantation (HCT)
Mommeja-Marin, Herve, Brundage, Thomas M, Margolskee, Dorothy J
Published in Biology of blood and marrow transplantation (01.02.2013)
Published in Biology of blood and marrow transplantation (01.02.2013)
Get full text
Journal Article
Brincidofovir for Prevention of Cytomegalovirus (CMV) after Allogeneic Hematopoietic Cell Transplantation (HCT) in CMV-Seropositive Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Trial
Marty, Francisco M., MD, Winston, Drew J., MD, Chemaly, Roy F., MD, MPH, Boeckh, Michael J., MD, Mullane, Kathlene M., DO, PharmD, Shore, Tsiporah B., MD, FRCPC, FACP, Papanicolaou, Genovefa A., MD, Morrison, Marion E, Brundage, Thomas M., MS, Mommeja-Marin, Hervé, MD
Published in Biology of blood and marrow transplantation (01.03.2016)
Published in Biology of blood and marrow transplantation (01.03.2016)
Get full text
Journal Article
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Grimley, Michael S., MD, Marón, Gabriela M., MD, Prasad, Vinod K., MD, Jacobsohn, David A., MD, Young, Jo-Anne H., MD, Chittick, Greg, Brundage, Thomas M., MS, Momméja-Marin, Hervé, MD
Published in Biology of blood and marrow transplantation (01.02.2015)
Published in Biology of blood and marrow transplantation (01.02.2015)
Get full text
Journal Article
Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients with Asymptomatic Adenovirus Viremia
Grimley, Michael, MD, Prasad, Vinod K., MD, Kurtzberg, Joanne, MD, Chemaly, Roy F., MD, MPH, FIDSA, FACP, Brundage, Thomas M, Wilson, Chad, Mommeja-Marin, Herve, MD
Published in Biology of blood and marrow transplantation (01.02.2014)
Published in Biology of blood and marrow transplantation (01.02.2014)
Get full text
Journal Article
Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients
Prasad, Vinod K., MD, Grimley, Michael, MD, Papanicolaou, Genovefa, MD, Yu, Lolie C., MD, Florescu, Diana F., MD, Brundage, Thomas M, Mommeja-Marin, Herve, MD, Kurtzberg, Joanne, MD
Published in Biology of blood and marrow transplantation (01.02.2014)
Published in Biology of blood and marrow transplantation (01.02.2014)
Get full text
Journal Article
Brincidofovir Is Not A Substrate For The Human Organic Anion Transporter 1 (Oat1): A Mechanistic Explanation For The Lack Of Nephrotoxicity Observed In Clinical Studies
Tippin, Timothy K, Morrison, Marion E, Brundage, Thomas M, Momméja-Marin, Hervé
Published in Therapeutic drug monitoring (16.11.2016)
Get more information
Published in Therapeutic drug monitoring (16.11.2016)
Journal Article
Brincidofovir Decreases Adenovirus Viral Burden, Which is Associated with Improved Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Brundage, Thomas M., Vainorius, Enrikas, Chittick, Greg, Nichols, Garrett
Published in Biology of blood and marrow transplantation (01.03.2018)
Published in Biology of blood and marrow transplantation (01.03.2018)
Get full text
Journal Article
539 - Brincidofovir Decreases Adenovirus Viral Burden, Which is Associated with Improved Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Brundage, Thomas M., Vainorius, Enrikas, Chittick, Greg, Nichols, Garrett
Published in Biology of blood and marrow transplantation (01.03.2018)
Published in Biology of blood and marrow transplantation (01.03.2018)
Get full text
Journal Article
Oral Brincidofovir Decreased HHV-6 Viremia in Hematopoietic Cell Transplant Recipients: Results from the Suppress Study
Hill, Joshua A, Zerr, Danielle, Nichols, Garrett, Brundage, Thomas M., Lanier, Randall, Boeckh, Michael J
Published in Biology of blood and marrow transplantation (01.03.2019)
Published in Biology of blood and marrow transplantation (01.03.2019)
Get full text
Journal Article
Screening and Treatment of Adenovirus Infection in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: Multicenter Survey of Transplant Centers in the United States
Papanicolaou, Genovefa A., Dadwal, Sanjeet S, Marón, Gabriela M., Chaudhury, Sonali, Hutcheson, Robert, Chandak, Aastha, Vainorius, Enrikas, Brundage, Thomas M., Mozaffari, Essy, Nichols, Garrett, Dvorak, Christopher C.
Published in Biology of blood and marrow transplantation (01.03.2019)
Published in Biology of blood and marrow transplantation (01.03.2019)
Get full text
Journal Article
46 - Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial
Prasad, Vinod K., Papanicolaou, Genovefa A., Marón, Gabriela M., Vainorius, Enrikas, Brundage, Thomas M., Chittick, Greg, Nichols, Garrett, Grimley, Michael S.
Published in Biology of blood and marrow transplantation (01.03.2017)
Published in Biology of blood and marrow transplantation (01.03.2017)
Get full text
Journal Article